OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor
Amr Abdin, Stefan D. Anker, Javed Butler, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 6, pp. 4444-4453
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Artificial intelligence and heart failure: A state‐of‐the‐art review
Muhammad Shahzeb Khan, Muhammad Sameer Arshad, Stephen J. Greene, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 9, pp. 1507-1525
Closed Access | Times Cited: 29

Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
Amr Abdin, Martin Schulz, Uwe Riemer, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3737-3750
Open Access | Times Cited: 26

Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies
Amr Abdin, Michael Böhm, Bahira Shahim, et al.
International Journal of Cardiology (2024) Vol. 412, pp. 132304-132304
Closed Access | Times Cited: 5

Clinical Review of Hypertensive Acute Heart Failure
Ratko Lasica, Lazar Djukanovic, Jovanka Vukmirović, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 133-133
Open Access | Times Cited: 4

The ADESTE trial: A phase 2 study of enibarcimab, a monoclonal antibody targeting adrenomedullin, in acute heart failure
Anggoro Budi Hartopo, Arinal Chairul Achyar, Hendry Purnasidha Bagaswoto, et al.
ESC Heart Failure (2025)
Open Access

A new simple chronic heart failure prognostic index based on five general parameters
Helena Hipólito-Reis, Carolina V. Guimaraes, Catarina Elias, et al.
International Journal of Cardiology (2025), pp. 133002-133002
Closed Access

Pharmacoequity measurement framework: A tool to reduce health disparities
Pranav Patel, Utibe R. Essien, Laura E. Happe
Journal of Managed Care & Specialty Pharmacy (2025) Vol. 31, Iss. 2, pp. 214-224
Closed Access

Mapping the recent researches on the treatment of heart failure
Yaqi Liu, Li Wang, Yan Xie, et al.
Asian Journal of Surgery (2025)
Open Access

Heart failure guideline implementation in developing countries: A testimony from Syria
Amr Abdin, Mohammad Bashar Izzat, Ahmad Rasheed Alsaadi, et al.
European Journal of Heart Failure (2025)
Open Access

Automated Detection of Reduced Ejection Fraction Using an ECG-Enabled Digital Stethoscope
Ling Guo, Gregg S. Pressman, Stefanus Tao Hwa Kieu, et al.
JACC Advances (2025) Vol. 4, Iss. 3, pp. 101619-101619
Open Access

A Case-Control Study on Risk Factors and Outcomes in Congestive Heart Failure
Mohammad Shakil Ahmad, Abdulrahman Obaid Matar Alharbi, Abdullah Tawakul, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access

Racial and ethnic disparities in longitudinal trajectories of hospitalizations in patients diagnosed with heart failure
Matthew E. Dupre, Radha Dhingra, Hanzhang Xu, et al.
American Heart Journal (2025)
Closed Access

Side effects and treatment initiation barriers of sodium–glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta‐analysis
Davor Vukadinović, Amr Abdin, Stefan D. Anker, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 9, pp. 1625-1632
Open Access | Times Cited: 20

A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction
Amr Abdin, Johann Bauersachs, Samira Soltani, et al.
ESC Heart Failure (2022) Vol. 10, Iss. 1, pp. 24-31
Open Access | Times Cited: 19

Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction
Michael Böhm, Amr Abdin, Jonathan Slawik, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 8, pp. 1429-1435
Open Access | Times Cited: 10

Deep Learning Models for Predicting Left Heart Abnormalities From Single-Lead Electrocardiogram for the Development of Wearable Devices
Masataka Satô, Satoshi Kodera, Naoto Setoguchi, et al.
Circulation Journal (2023) Vol. 88, Iss. 1, pp. 146-156
Open Access | Times Cited: 8

Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts
José Antonio Magaña Serrano, José Ángel Cigarroa López, Adolfo Chávez Mendoza, et al.
Drugs in Context (2024) Vol. 13, pp. 1-18
Open Access | Times Cited: 2

Diagnostic accuracy of prehospital lung ultrasound for acute decompensated heart failure: A systematic review and Meta-analysis
Frances M. Russell, Nicholas E. Harrison, Oliver Hobson, et al.
The American Journal of Emergency Medicine (2024) Vol. 80, pp. 91-98
Closed Access | Times Cited: 2

Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits
Zixi Zhang, Cancan Wang, Tao Tu, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 3, pp. 329-342
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top